Kinetic Concepts Inc. (KCI) is a leading global medical technology company devoted to understanding, developing and commercializing innovative, high-technology transformational healing solutions for customers and patients in more than 25 countries around the world. A pioneer in Negative Pressure Wound Therapy, the company’s Vacuum Assisted Closure® Therapy (V.A.C.® Therapy), has been clinically demonstrated to help promote wound healing. KCI’s proprietary technologies have revolutionized the way in which caregivers treat a wide variety of wound types with V.A.C. Therapy used on more than 7 million patients worldwide.
KCI is committed to advancing the science of healing and positively impacting patient care by developing customer-driven innovation to meet the evolving needs of healthcare professionals. To protect its innovations and proprietary approach to wound healing, each year KCI files a significant number of U.S. patent applications and nationalizes a significant number of foreign applications using the corresponding PCT application.
With Growth, Comes Change
Prior to the 1995 introduction of V.A.C. Therapy, KCI had handled all of its patent preparation and prosecution work in-house. The tremendous growth and market adoption of V.A.C. Therapy as a standard of care for advanced wounds required that the company devote more resources each year to R&D, product refinement, expansion and intellectual property (IP). By 2006, KCI’s growth necessitated a review of its domestic and foreign filing procedures. KCI’s team for handling international patent filings was looking for better ways to improve its business.